The governor of São Paulo, João Doria (PSDB), authorized the state government to start negotiations with pharmaceutical company Pfizer to acquire the Covid-19 vaccine intended for children. Despite having the same active ingredient as immunizing agents applied to adults, the pediatric formulation has a lower dosage and must meet other specifications.
The start of vaccination of children, therefore, is conditional on the delivery of adapted vaccines, but when this will occur there is still no forecast.
read more:
This Thursday morning (16), the National Health Surveillance Agency (Anvisa) authorized the application of the Pfizer vaccine to the public from 5 to 11 years old. The inclusion of the new group was published in the Diário Oficial da União in the afternoon of the same day. With this registration, the Ministry of Health is free to start applying immunizations to children – which is already done in most countries. The ministry, however, has not yet given a deadline to start immunizing this age group.
With this, under authorization from Doria, the Health Department of the State of São Paulo sent a letter to Pfizer this Thursday, communicating the state government’s interest in acquiring the doses and streamlining the process. The São Paulo administration sent yet another letter, this time to the Ministry of Health, requesting release and immediate availability of doses for immunization of children.
The documents were sent after the Minister of Health, Marcelo Queiroga, having stated that there will be no vaccination for children in 2021. According to him, so far there is no reservation of doses or date forecast for the start of the group’s immunization.
“An analysis needs to be done,” said Queiroga.
Brazil still does not have the so-called pediatric doses of the Pfizer vaccine on national soil, since the vaccination of children was not approved by Anvisa until then.
Even so, the pharmaceutical company explained that the third contract signed with the Brazilian government, which will allow the supply of 100 million anti-covid immunizers in 2022, includes the possibility of delivering versions for different age groups. Availability depends on what is requested by the Ministry of Health.
Source: Full News
The governor of São Paulo, João Doria (PSDB), authorized the state government to start negotiations with pharmaceutical company Pfizer to acquire the Covid-19 vaccine intended for children. Despite having the same active ingredient as immunizing agents applied to adults, the pediatric formulation has a lower dosage and must meet other specifications.
The start of vaccination of children, therefore, is conditional on the delivery of adapted vaccines, but when this will occur there is still no forecast.
read more:
This Thursday morning (16), the National Health Surveillance Agency (Anvisa) authorized the application of the Pfizer vaccine to the public from 5 to 11 years old. The inclusion of the new group was published in the Diário Oficial da União in the afternoon of the same day. With this registration, the Ministry of Health is free to start applying immunizations to children – which is already done in most countries. The ministry, however, has not yet given a deadline to start immunizing this age group.
With this, under authorization from Doria, the Health Department of the State of São Paulo sent a letter to Pfizer this Thursday, communicating the state government’s interest in acquiring the doses and streamlining the process. The São Paulo administration sent yet another letter, this time to the Ministry of Health, requesting release and immediate availability of doses for immunization of children.
The documents were sent after the Minister of Health, Marcelo Queiroga, having stated that there will be no vaccination for children in 2021. According to him, so far there is no reservation of doses or date forecast for the start of the group’s immunization.
“An analysis needs to be done,” said Queiroga.
Brazil still does not have the so-called pediatric doses of the Pfizer vaccine on national soil, since the vaccination of children was not approved by Anvisa until then.
Even so, the pharmaceutical company explained that the third contract signed with the Brazilian government, which will allow the supply of 100 million anti-covid immunizers in 2022, includes the possibility of delivering versions for different age groups. Availability depends on what is requested by the Ministry of Health.
Source: Full News
